To Investigate Efficacy of FOL-005 on Hair Growth on Scalp Skin

Status Completed

Clinical Trial Summary

The trial was a multicentre, randomised, double-blind, placebo controlled phase 2 trial. 60 healthy bald male subjects diagnosed with alopecia, who are between 18 and 55 years old and provide written informed consent were eligible for inclusion. The trial period consisted of a screening period of up to 3 weeks followed by 12 weeks of dosing, three times per week. Each subject received two doses of the five trial treatment doses (placebo, 0.00625, 0.025, 0.050, and 0.100 μg respectively). The doses were given as intradermal injections. On each volunteer, two treatment areas were placed on the head and the two selected doses were allocated to the respective treatment areas according to the randomisation scheme. The treatment areas were selected on the border between the bald surface and the surface with hair. The effect on hair growth was measured by the use of Trichoscan imaging and measuring method at week 8 and 12. A baseline measaure was taken at day 0.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT03467412
Study type	Interventional
Source	Follicum AB
Contact
Status	Completed
Phase	Phase 2
Start date	February 27, 2018
Completion date	August 22, 2018

View Details

See also
Status	Clinical Trial	Phase
Recruiting	`NCT06110377` - MALE HAIR LOSS - Treatment With Dutasteride Mesotherapy x Dutasteride MMP Technique (Injections With Tattoo Machine)	Phase 4
Recruiting	`NCT05611593` - Study to Evaluate Safety & Usability of a New Formulation for Male Androgenetic Alopecia	Phase 1
Completed	`NCT03676400` - Hair Growth Efficacy and Safety of NGF-574H in Adult With Androgenic Alopecia	N/A
Recruiting	`NCT05938569` - Computer-Assisted Hair Restoration Study Using ARTAS System	N/A
Not yet recruiting	`NCT06326359` - Autologous Stromal Vascular Fraction in Treatment of Male Androgenic Alopecia	N/A
Recruiting	`NCT05426629` - Hydraderm for Androgenic Alopecia	Phase 4
Recruiting	`NCT05827991` - A Clinical Observation of 1565nm Non-ablative Fractional Laser in the Treatment of Androgenic Alopecia	N/A
Recruiting	`NCT05369481` - Comparison Between Efficacy of Topical Sildenafil 2% and Topical Minoxidil 5% in Treatment of Androgenic Alopecia	N/A
Not yet recruiting	`NCT06292533` - Effectiveness of Ultrapulse for the Treatment of Androgenic Alopecia Among Malaysian: A Quasi-experimental Study	N/A
Completed	`NCT02824380` - Pharmacokinetics/ Pharmacodynamics and Safety of DA-4001 in Healthy Male Subjects With Androgenic Alopecia	Phase 1
Completed	`NCT06112782` - Keravive by Hydrafacial for Scalp Health and Enhanced Hair Quality	N/A
Completed	`NCT02594046` - The Effect of Allogeneic Human Adipose Derived Stem Cell Component Extract on Androgenic Alopecia	N/A
Recruiting	`NCT05435625` - Fractional Laser Versus Radiofrequency in Androgenetic Alopecia	N/A
Completed	`NCT05450861` - Effect of the Composition From Fish on Promoting Hair Growth	N/A
Completed	`NCT03506503` - Condensed Nanofat Grafting for Treatment of Androgenetic Alopecia	N/A
Completed	`NCT01852487` - Effect of Pumpkin Seed Oil on Hair Growth in Men With Androgenetic Alopecia	N/A
Not yet recruiting	`NCT03474718` - Evaluating the Efficacy of Platelet-rich Plasma Therapy in the Treatment of Androgenic Alopecia	Early Phase 1
Active, not recruiting	`NCT02914587` - Computer-Assisted Hair Implantation Using ARTAS System VS Manual Implantation Technique Hair Restoration Study	N/A
Completed	`NCT04341363` - Follicular Revival in Androgenic Alopecia: Evaluating Use of Micro-needling	N/A
Completed	`NCT04450602` - A Study Evaluating the Hair Regrowth Efficacy and Safety of ALRV5XR in Female Subjects With Hair Loss	N/A